XML 80 R67.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Reporting - Schedule of significant segment expenses (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]    
General and administrative expense $ 18,613 $ 12,688
Total operating expenses 70,577 43,000
Other income, net 3,924 2,674
Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds 30,900 (76,211)
Provision for income taxes (431) 0
Net loss and comprehensive loss (36,184) (116,537)
Operating Segments [Member]    
Segment Reporting Information [Line Items]    
Tegoprubart - kidney transplantation programs 27,452 11,940
Tegoprubart - other development programs 306 3,186
Manufacturing 12,448 8,048
Personnel-related 10,706 8,351
Stock-based compensation 13,122 6,545
General and administrative expense 6,543 4,930
Total operating expenses 70,577 43,000
Loss from operations (70,577) (43,000)
Other income, net 3,924 2,674
Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds 30,900 (76,211)
Provision for income taxes (431)  
Net loss and comprehensive loss $ (36,184) $ (116,537)